They have been demonstrated to partake in the pathobiology of pancreatic cancer via different mechanisms, among which is the modulation of cancer-related pathways such as JAK2/STAT3, EGFR/MAPK, ERK, NOTCH, and PTEN pathways. This evidence concerns the gene JAK2 and cancer.